Download Files:
Calcium glycerophosphate
SKU
HY-B2203-1 g
Category Reference compound
Tags Metabolic Disease, Metabolic Enzyme/Protease, Phosphatase
$50 – $60
Products Details
Product Description
– Calcium glycerophosphate is an inhibitor of intestinal alkaline phosphatase F3. Calcium glycerophosphate is a source of calcium and phosphorus in total parenteral nutrition solutions[1][2].
Web ID
– HY-B2203
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Metabolism-sugar/lipid metabolism
Molecular Formula
– C3H7CaO6P
References
– [1]Datta P, et al. Calcium glycerophosphate preserves transepithelial integrity in the Caco-2 model of intestinal transport. World J Gastroenterol. 2015;21(30):9055-9066. |[2]Draper HH, et al. Calcium glycerophosphate as a source of calcium and phosphorus in total parenteral nutrition solutions. JPEN J Parenter Enteral Nutr. 1991;15(2):176-180.
CAS Number
– 27214-00-2
Molecular Weight
– 210.14
Compound Purity
– 98.0
SMILES
– O=P([O-])([O-])OCC(O)CO.[Ca+2]
Clinical Information
– Phase 2
Research Area
– Metabolic Disease
Solubility
– DMSO : < 1 mg/mL (ultrasonic;warming;heat to 60°C)|H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C)
Target
– Phosphatase
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.